Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Apr;14(4):458-62.
doi: 10.1023/a:1012043315093.

Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant

R H Müller  1 , D Rühl, S Runge, K Schulze-Forster, W Mehnert
Affiliations

Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant

R H Müller et al. Pharm Res. 1997 Apr.

Abstract

Purpose: Assessment of the in vitro cytotoxicity of solid lipid nanoparticles (SLNs) as a function of lipid matrix (Dynasan 114, Compritol ATO 888), and stabilizing surfactant (poloxamers, Tween 80, soya lecithin, and sodium dodecyl sulphate). Comparison with other colloidal carriers should determine their potential use in the clinic.

Methods: SLNs were produced by high pressure homogenisation. Cytotoxicity was assessed by measuring the viability of HL60 cells and human granulocytes after incubation with SLNs. Particle internalisation was quantified by chemiluminescence measurements.

Results: The nature of the lipid had no effect on viability; distinct differences were found for the surfactants. Binding to the SLN surface reduced markedly the cytotoxic effect of the surfactants, e.g., up to a factor of 65 for poloxamer 184. The permanent HL60 cell line-differentiated from cells with granulocyte characteristics by retinoic acid treatment-yielded results identical to freshly isolated human granulocytes. In general, the SLNs showed a lower cytotoxicity compared to polyalkylcyanoacrylate and polylactic/glycolic acid (PLA/ GA) nanoparticles.

Conclusions: Because the results are identical when using human granulocytes, differentiated HL60 cells can be used as an easily accessible in vitro test system for i.v. injectable SLN formulations. The SLNs appear suitable as a drug carrier system for potential intravenous use due to their very low cytotoxicity in vitro.

PubMed Disclaimer

References

    1. Crit Rev Ther Drug Carrier Syst. 1988;5(1):1-20 - PubMed
    1. Invest New Drugs. 1992 Aug;10(3):191-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Mar;74(3):1204-8 - PubMed
    1. J Pharm Sci. 1984 Jul;73(7):980-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 - PubMed

LinkOut - more resources